Dermacell
Payments companies reported to CMS as associated with Dermacell. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Dermacell, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Dermacell
These are the largest totals companies reported as associated with Dermacell. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| David Weintritt | Alexandria, VA | Surgery | $23,000.00 |
| Eleanor Bucholz | Maywood, IL | Plastic and Reconstructive Surgery | $15,575.00 |
| Mark Venturi | Mc Lean, VA | Plastic and Reconstructive Surgery | $15,250.00 |
| Jessica Maxwell | Omaha, NE | Surgical Oncology | $11,200.00 |
| Joshua Lemmon | Richardson, TX | Plastic and Reconstructive Surgery | $10,065.01 |
| Anne Peled | San Francisco, CA | Plastic Surgery | $10,029.00 |
| Andrea Abbott | Charleston, SC | Surgical Oncology | $9,124.50 |
| Siba Haykal | New Haven, CT | Plastic Surgery | $7,800.00 |
| Stephanie Koonce | Rogers, AR | Plastic Surgery | $7,600.00 |
| Sheldon Feldman | New York, NY | Surgical Oncology | $7,600.00 |
Prescribed Dermacell?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.